Literature DB >> 12647787

Effects of the proapoptotic drug prodigiosin on cell cycle-related proteins in Jurkat T cells.

R Pérez-Tomás1, B Montaner.   

Abstract

Prodigiosin (PG) is a red pigment produced by Serratia marcescens with immunosuppressive and apoptotic activities. In this study, we sought to examine the effect of PG on cell cycle-related proteins. The antiproliferative activity of PG was tested using human Jurkat leukaemia T cells in culture. PG-inhibited cell proliferation was determined using thymidine incorporation assay. PG-arrested cell cycle was analysed using immunoblot analysis with specific antibodies against cell cycle-related proteins and kinase assays of cdk2. Apoptosis was determined by Hoechst staining and analysis of DNA fragmentation. PG inhibited cyclin E, cdk2, p27 and p21, the induction of the cyclin A-cdk2 and cyclin E-cdk2 kinase activity, and the phosphorylation of Rb in leukaemic Jurkat cells. We confirmed that PG induces apoptosis by the characteristic DNA laddering pattern and condensed nuclei or apoptotic bodies identified by fluorescence microscopy. These results indicate that PG and other family members form a new group of molecules with a common mechanism of action and specific molecular targets, raising the possibility of their therapeutic use as antineoplastic drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12647787     DOI: 10.14670/HH-18.379

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  2 in total

1.  Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line.

Authors:  Marta Monge; Marta Vilaseca; Vanessa Soto-Cerrato; Beatriz Montaner; Ernest Giralt; Ricardo Pérez-Tomás
Journal:  Invest New Drugs       Date:  2007-02       Impact factor: 3.850

Review 2.  Prodigiosin and its potential applications.

Authors:  N Darshan; H K Manonmani
Journal:  J Food Sci Technol       Date:  2015-01-24       Impact factor: 2.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.